ArticleDrug safety2022

Authors' Reply to Noguchi's comment on: "Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data."

John-Michael Gamble et al.PubMed ↗Publisher ↗

No numbers read from the abstract.